Article
Circulating Tumor DNA in Lymphoma: Principles and Future Directions
30 Sept 2021
Abstract excerpt
Lymphomas are heterogeneous tumors with striking genetic diversity and variable outcomes even within pathologic diagnoses. Treatment response assessment relies on radiologic and nuclear scans, which cannot detect disease at the molecular level. Molecular tumor analyses require invasive tissue biopsies that cannot accurately capture spatial tumor heterogeneity within each patient. Circulating tumor DNA (ctDNA) is...
Topics
Join the communities discussing this publication.